Other studies have shown that formononetin enhances T cells’ activity and killing ability by inhibiting the PD-L1 expression on the cell surface, thereby inhibiting tumor proliferation, angiogenesis, migration, and invasion (90). The gene discussed is CD274; the disease is neoplasm.